134 related articles for article (PubMed ID: 2998429)
21. Effect of low dose methotrexate on neutrophil chemotaxis induced by leukotriene B4 and complement C5a.
Suarez CR; Pickett WC; Bell DH; McClintock DK; Oronsky AL; Kerwar SS
J Rheumatol; 1987 Feb; 14(1):9-11. PubMed ID: 3033240
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-enhanced leukotriene B4 generation and chemotaxis in human neutrophils.
Meyer JD; Yurt RW; Duhaney R; Hesse DG; Tracey KJ; Fong YM; Verma M; Shires GT; Dineen P; Lowry SF
Arch Surg; 1988 Dec; 123(12):1454-8. PubMed ID: 2847685
[TBL] [Abstract][Full Text] [Related]
23. Effect of leukotriene B5 on the accumulation of polymorphonuclear leukocytes in unstimulated and leukotriene B4-stimulated human skin.
Wozel G; Chang A; Barth J; Happle R; van de Kerkhof PC
Skin Pharmacol; 1990; 3(1):45-8. PubMed ID: 2167697
[No Abstract] [Full Text] [Related]
24. Dapsone hydroxylamine inhibits the LTB4-induced chemotaxis of polymorphonuclear leukocytes into human skin: results of a pilot study.
Wozel G; Blasum C; Winter C; Gerlach B
Inflamm Res; 1997 Oct; 46(10):420-2. PubMed ID: 9372316
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil polymorphonuclears, mediators and the pathogenesis of psoriasis.
Greaves MW
Br J Dermatol; 1983 Jul; 109(1):115-8. PubMed ID: 6305385
[No Abstract] [Full Text] [Related]
26. Production of intraepidermal microabscesses by topical application of leukotriene B4.
Camp R; Jones RR; Brain S; Woollard P; Greaves M
J Invest Dermatol; 1984 Feb; 82(2):202-4. PubMed ID: 6319504
[TBL] [Abstract][Full Text] [Related]
27. 6-trans-leukotriene B4 is a neutrophil chemotaxin in the guinea pig dermis.
Fretland DJ; Widomski DL; Anglin CP; Walsh RE; Levin S; Gaginella TS
J Leukoc Biol; 1991 Mar; 49(3):283-8. PubMed ID: 1847716
[TBL] [Abstract][Full Text] [Related]
28. The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin.
Wozel G; Chang A; Zultak M; Czarnetzki BM; Happle R; Barth J; van de Kerkhof PC
Arch Dermatol Res; 1991; 283(3):158-61. PubMed ID: 1651071
[TBL] [Abstract][Full Text] [Related]
29. Epidermal proliferation and accumulation of polymorphonuclear leukocytes in the psoriatic lesion.
Beurskens T; Chang A; van Erp PE; van de Kerkhof PC
Dermatologica; 1989; 178(2):67-72. PubMed ID: 2924984
[TBL] [Abstract][Full Text] [Related]
30. Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4.
Bauer FW; van de Kerkhof PC; Maassen-de Grood RM
Br J Dermatol; 1986 Apr; 114(4):409-12. PubMed ID: 3008801
[TBL] [Abstract][Full Text] [Related]
31. Neutrophil chemotaxis in psoriasis before and after PUVA therapy.
Guillot B; Guilhou JJ; Vendrel JP; Meynadier J
Arch Dermatol Res; 1983; 275(1):19-22. PubMed ID: 6847241
[TBL] [Abstract][Full Text] [Related]
32. Intra-epidermal accumulation of polymorphonuclear leukocytes in persistent palmoplantar pustulosis during treatment with acitretin.
van de Kerkhof PC; Chang A; van Dooren-Greebe R; Geiger JM; Happle R
Acta Derm Venereol; 1988; 68(6):499-503. PubMed ID: 2467488
[TBL] [Abstract][Full Text] [Related]
33. Effect of PUVA treatment on the locomotion of polymorphonuclear leukocytes and mononuclear cells in psoriasis.
Silny W; Pehamberger H; Zielinsky C; Gschnait F
J Invest Dermatol; 1980 Aug; 75(2):187-8. PubMed ID: 6893337
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil chemotaxis in psoriasis.
Wahba A; Cohen H; Bar-Eli M; Callily R
Acta Derm Venereol; 1979; 59(5):441-5. PubMed ID: 93368
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships.
Lee TH; Lympany P; Crea AE; Spur BW
Biochem Biophys Res Commun; 1991 Nov; 180(3):1416-21. PubMed ID: 1659416
[TBL] [Abstract][Full Text] [Related]
36. Chitin and chitosan stimulate canine polymorphonuclear cells to release leukotriene B4 and prostaglandin E2.
Usami Y; Okamoto Y; Takayama T; Shigemasa Y; Minami S
J Biomed Mater Res; 1998 Dec; 42(4):517-22. PubMed ID: 9827674
[TBL] [Abstract][Full Text] [Related]
37. Migration of polymorphonuclear leukocytes in psoriasis.
van de Kerkhof PC; Chang A
Skin Pharmacol; 1989; 2(3):138-54. PubMed ID: 2697247
[TBL] [Abstract][Full Text] [Related]
38. Biological properties of dihydro-leukotriene B4, an alternative leukotriene B4 metabolite.
Kaever V; Damerau B; Wessel K; Resch K
FEBS Lett; 1988 Apr; 231(2):385-8. PubMed ID: 2834233
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of leukotriene B4-specific chemotactic deactivation of human polymorphonuclear leukocytes.
Boggs JM; Goetzl EJ
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():399-402. PubMed ID: 1847775
[No Abstract] [Full Text] [Related]
40. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
